Health-care wine for inhibiting tumor growth and its preparation process

Through scientific formulation and refined processing, the combination of highland barley wine with raw materials such as Tibetan mushroom extract has solved the problems of low dissolution rate of active ingredients and unstable quality in traditional health wines, and has achieved the preparation of health wines that can effectively inhibit tumor growth.

CN122405397APending Publication Date: 2026-07-17YUNNAN ZHONGYUNCHUN TRADING CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
YUNNAN ZHONGYUNCHUN TRADING CO LTD
Filing Date
2026-04-30
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

Traditional tumor-suppressing health wines suffer from problems such as low dissolution rate of active ingredients, many impurities, and unstable product quality in terms of raw material formulation and preparation process, thus failing to effectively inhibit tumor growth.

Method used

Using highland barley wine as the base, it is combined with Tibetan mushroom extract and medicinal and edible raw materials such as dandelion and cinnamon. Through a series of refined processes such as cell wall breaking and drying, pre-soaking association, shaking extraction, purification and clarification, and gradient temperature sterilization, combined with ultrasonic solubilization, biological clarification, and nanofiltration purification, the dissolution rate and stability of active ingredients are ensured.

Benefits of technology

The active ingredients have been efficiently dissolved and stabilized, resulting in a health wine with good tumor-inhibiting effects and drinking quality. The product's quality stability and safety are guaranteed.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122405397A_ABST
    Figure CN122405397A_ABST
Patent Text Reader

Abstract

本发明公开了用于抑制肿瘤生长的保健酒及其制备工艺,涉及保健酒技术领域,该保健酒按重量份计包括:青稞酒50‑600份、藏密菇提取物3‑10份、蒲公英3‑12份、肉桂5‑15份、甘草4‑12份、黄芪5‑15份、半枝莲3‑10份、山楂4‑16份;所述藏密菇提取物为青藏高原海拔3500m以上产区的藏密菇子实体经提取制得,其中藏密菇多糖含量≥30%、萜类内酯含量≥5%;所述青稞酒由藏青稞经低温生物发酵、真空低温蒸馏制备,酒精度为38%vol‑45%vol;本发明科学配比青稞酒与多种天然原料,结合专属工艺使活性成分协同,抑制肿瘤生长,通过精细化制备把控各环节,从原料处理到灌装,保留与增效活性成分,保证品质安全,提升饮用价值。
Need to check novelty before this filing date? Find Prior Art